Emergent BioSolutions
EBS
#8541
Rank
A$0.39 B
Marketcap
A$7.73
Share price
-6.36%
Change (1 day)
-49.24%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): A-$7.33

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is A-$7.57. In 2025 the company made an earnings per share (EPS) of A$1.43 an increase over its 2024 EPS that were of A-$5.45.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$7.33-614.07%
2025A$1.43-126.17%
2024A-$5.45-75.61%
2023A-$22.35232.21%
2022A-$6.73-203.46%
2021A$6.50-25.09%
2020A$8.68445.28%
2019A$1.59-15.2%
2018A$1.88-35.9%
2017A$2.9369.57%
2016A$1.73-27.67%
2015A$2.3965.63%
2014A$1.4411.63%
2013A$1.2932.31%
2012A$0.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.49-119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.32-157.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
A-$2.70-64.29%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.80-110.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.53-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.68-108.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel